Abstract:One of the most challenging puzzles in drug discovery is the identification and characterization of candidate drug of well-balanced profile between efficacy and safety. So far, extensive efforts have been made to evaluate this balance by estimating the quantitative structure-therapeutic relationship and exploring target profile of adverse drug reaction. Particularly, the therapeutic index (TI) has emerged as a key indicator illustrating this delicate balance, and a clinically successful agent requires a sufficient TI suitable for it corresponding indication. However, the TI information are largely unknown for most drugs, and the mechanism underlying the drugs with narrow TI (NTI drugs) is still elusive. In this study, the collective effects of human protein-protein interaction (PPI) network and biological system profile on the drugs' efficacy-safety balance were systematically evaluated. First, a comprehensive literature review of the FDA approved drugs confirmed their NTI status. Second, a popular feature selection algorithm based on artificial intelligence (AI) was adopted to identify key factors differencing the target mechanism between NTI and non-NTI drugs. Finally, this work revealed that the targets of NTI drugs were highly centralized and connected in human PPI network, and the number of similarity proteins and affiliated signaling pathways of the corresponding targets was much higher than those of non-NTI drugs. These findings together with the newly discovered features or feature groups clarified the key factors indicating drug's narrow TI, and could thus provide a novel direction for determining the delicate drug efficacy-safety balance.

Distribution of drug target protein in protein network

Learning the Drug Target-Likeness of A Protein

Does Drug-Target Have A Likeness?

Peeling the drug target proteins network by a core decomposition method

Drug—target network

Progress and Problems in the Exploration of Therapeutic Targets.

Recent Advances on the Network Models in Target-based Drug Discovery

Are Topological Properties of Drug Targets Based on Protein-Protein Interaction Network Ready to Predict Potential Drug Targets?

Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs

Drug Target Proteins Prediction with Network Topological Indices

Predicting Drug-Target Interaction Networks Based on Functional Groups and Biological Features.

DrugProtAI: A guide to the future research of investigational target proteins

Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification

Multi-level bioinformatics resources support drug target discovery of protein-protein interactions

Therapeutic targets: Progress of their exploration and investigation of their characteristics (vol 58, pg 259, 2006)

Determining the Balance Between Drug Efficacy and Safety by the Network and Biological System Profile of Its Therapeutic Target

[Network Pharmacology and Drug Discovery].

Comprehensive Analysis Of Cancer Drugs Based On Human Protein-Protein Interaction Network Profiles Of These Targets

Identification of Human Protein Drug Targets Homologues with Data Mining

The exploration of network motifs as potential drug targets from post-translational regulatory networks

Targets of drugs are generally, and targets of drugs having side effects are specifically good spreaders of human interactome perturbations